News and Comments

AGEN: IRRATIONAL REACTION AGAINST EXPECTED NEWS

  Thursday, March 20, 2014
 More...

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...

JAKAFI DEVELOPED BY INCYTE MET THE PRIMARY ENDPOINTS FOR POLYCYTHEMIA VERA

  Friday, March 07, 2014

Incyte (INCY) announced results from pivotal Phase 3 trial of Jakafi (ruxolitinib) in polycythemia vera patients who are resistant to or intolerant of hydroxyurea. The results met the primary endpoints; achieving phlebotomy independence and reducing spleen size by 35 percent or more compared to best available therapy.  More...


Recent Postings


Archive


Tags

AGOS (ARGS) galapagos (GLPG) Revlimid (lenolidamide) AstraZeneca (AZN) Advaxis (ADXS) Cytokinetics (CYTK) Idenix (IDIX) Telaprevir Galena (GALE) MODERNA Inovio (INO) Incyte (INCY) KERYX (KERX) Vitae Pharmaceuticals (VTAE) NANTKWEST (NK) BIOMARIN (BMRN) Amgen (AMGN) Biocryst (BCRX) Editas (EDIT) Sanofi-Aventis (SAN) ACADIA (ACAD) Bellicum (BLCM) Alder Biopharmaceuticals (ALDR) Dendreon (DNDN) Abbott Laboratories (ABT) Anacor (ANAC) Trastuzumab-DM1 Intercept (ICPT) Alnylam (ALNY) Ocular Therapeutix (OCUL) Theravance (THRX) Adaptimmune (ADAP) HALOZYME (HALO) Regeneron (REGN) C4 Therapeutics Rapamune Prosensa (RNA) Xoma (XOMA) PTC Therapeutics (PTCT) Sanofi (SNY) VANDA (VNDA) ADVENTRIX (ANX) Biogen Idec (BIIB) CompuGen (CGEN) Multiple Myeloma Intermune (ITMN) Micromet (MITI) Onyx (ONXX) NOVOCURE (NVCR) TOKAI (TKAOI) INNOVIVA (INVA) Seattle Genetics (SGEN) Human Longevity (HLI) AERIE PHARMACEUTICALS Herceptin Global Cell Therapeutics (GBT) OSI (OSIP) Agenus (AGEN Elan (ELN) Ziofpharm (ZIOP) Tysabri IDERA (IDRA) GlaxoSmithKline (GSK) Anadys (ANDS) Intrexon (XON) Sanofi (SNA) Ionis (IONS) SYNTA (SNTA) ARCA (ABIO) Human Genome Sciences (HGSI) NEKTAR (NKTR)) Illumina (ILMN) KITE (KITE) Bristol-Myers Squibb (BMY) Exelixis (EXEL) ImmunoGen (IMGN) Vertex (VRTX) Gilead (GILD) ISIS (ISIS) Valeant Pharmaceuticals International (VRX) SUNESIS PHARMACEUTICALS (SNSS) Mirati Therapeutics (MRTX) JUNO (JUNO) ABBVIE (ABBV) Roche (ROCHE) Sequenom (SQNM) Theravance Bio Pharma (TBPH) Sangamo (SGMO) Ariad (ARIA) Benlysta (belimumab) Sarepta (SRPT) Ridaforolimus ARGOS (ARGS) GUARDIAN HEALTH Roche (RHHBY) Genentech Spike Therapeutics (ONCE) CEMPRA (CEMP) Auspex (ASPX) Prolor Biotech (PBTH) Pluristem (PSTI) REGULUS (RGLS) Zerenex ZALTRAP™ Velcade (bortezomib) RenenxBio (RGNX) Aimmune Therapeutics (AIMT) Jazz Pharmaceuticals (JAZZ) SERES THERAPEUTICS (MCRB) Agenus (AGEN) Endometrial Cancer CRISPR Therapeutics (CRSP) Array Pharmaceuticals (ARRY) Dynavax (DVAX) Merck (MRK)